Chevrier, Thomas https://orcid.org/0009-0006-4108-5698
Bonhommeau, Sylvain https://orcid.org/0000-0002-0882-5918
Thompson, Michael https://orcid.org/0000-0002-2914-1080
Farley, Jessica https://orcid.org/0000-0002-5047-746X
Del Vecchio, Giorgia https://orcid.org/0000-0001-5156-3231
Nieblas, Anne-Elise https://orcid.org/0000-0002-3974-8484
Cowart, Dominique A. https://orcid.org/0000-0002-2581-0355
Nguyễn, Julie Imbert https://orcid.org/0009-0001-9389-9419
Bernard, Serge https://orcid.org/0000-0003-1772-0592
Guiguen, Yann https://orcid.org/0000-0001-5464-6219
Cabau, Cedric https://orcid.org/0000-0001-8560-4003
Klopp, Christophe https://orcid.org/0000-0001-7126-5477
Zoller, Joseph A. https://orcid.org/0000-0001-6309-0291
Horvath, Steve https://orcid.org/0000-0002-4110-3589
Brooke, Robert https://orcid.org/0000-0001-8492-5198
Lu, Ake T. https://orcid.org/0000-0002-2866-7961
Pellegrini, Matteo https://orcid.org/0000-0001-9355-9564
Chanut, Jérémie
Funding for this research was provided by:
EU-FEAMP (#PFEA400020DM0980001)
EU FEP (#13/1210964/FAV1)
Article History
Received: 1 February 2026
Accepted: 3 March 2026
First Online: 24 March 2026
Change Date: 29 April 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11357-026-02287-8
Declarations
: The Regents of the University of California are the sole owner of patents and patent applications directed at epigenetic biomarkers and the mammalian methylation array platform for which Steve Horvath is a named inventor; SH is a founder and paid consultant of the non-profit Epigenetic Clock Development Foundation that licenses these patents. SH is a Principal Investigator at the Altos Labs, Cambridge Institute of Science. The other authors have non-financial and no conflicts of interest to declare.